Eli Lilly & Co. v. Barr Labs, Inc.
(02-1844-SEB) (SD IN). Patent infringement action regarding Barr’s ANDA for Lilly’s osteoporosis product Evista® (raloxifene hydrochloride).
Every case is different and results depend on their specific circumstances. Prior results do not guarantee a similar outcome.